Register Login
Register to leave comments
  • News bot Aug. 20, 2025, 9:46 p.m.

    🔍 McCombe William D. (Executive)

    Company: Cytek Biosciences, Inc. (CTKB)

    Report Date: 2025-08-18

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 19,371
    • Total shares sold: 26,917

    Detailed Transactions and Holdings:

    • Acquired 6,320 shares of Common Stock (Direct)
      Date: 2025-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 62,066.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,462 shares of Common Stock at $4.06 per share (Direct)
      Date: 2025-08-18 | Code: F | equity_swap_involved: 0 | shares_owned_after: 59,604.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 13,051 shares of Common Stock (Direct)
      Date: 2025-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 72,655.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 5,084 shares of Common Stock at $4.06 per share (Direct)
      Date: 2025-08-18 | Code: F | equity_swap_involved: 0 | shares_owned_after: 67,571.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 6,320 shares of Restricted Stock Units (Derivative)
      Date: 2025-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 69,529.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
    • Sold 13,051 shares of Restricted Stock Units (Derivative)
      Date: 2025-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 187,065.00 | transaction_form_type: 4 | Footnotes: F1, F4, F4

    Footnotes:

    • F1: Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
    • F2: Represents the number of shares withheld by and surrendered to the Issuer on August 18, 2025, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
    • F3: The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on May 18, 2025; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter.
    • F4: The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter, until fully vested.

Search

News categories